Ma X - Search Results

1

GRIM-19 associates with the serine protease HtrA2 for promoting cell death.

Ma X, Kalakonda S, Srinivasula SM, Reddy SP, Platanias LC, Kalvakolanu DV. Ma X, et al. Oncogene. 2007 Jul 19;26(33):4842-9. doi: 10.1038/sj.onc.1210287. Epub 2007 Feb 12. Oncogene. 2007. PMID: 17297443

2

Regulation of interferon and retinoic acid-induced cell death activation through thioredoxin reductase.

Ma X, Karra S, Guo W, Lindner DJ, Hu J, Angell JE, Hofmann ER, Reddy SP, Kalvakolanu DV. Ma X, et al. J Biol Chem. 2001 Jul 6;276(27):24843-54. doi: 10.1074/jbc.M100380200. Epub 2001 Apr 30. J Biol Chem. 2001. PMID: 11331281 Free article.

3

Thioredoxin participates in a cell death pathway induced by interferon and retinoid combination.

Ma X, Karra S, Lindner DJ, Hu J, Reddy SP, Kimchi A, Yodoi J, Kalvakolanu DV. Ma X, et al. Oncogene. 2001 Jun 21;20(28):3703-15. doi: 10.1038/sj.onc.1204477. Oncogene. 2001. PMID: 11439333

4

Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.

Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP, Kalvakolanu DV. Hu J, et al. Among authors: ma x. Oncogene. 2001 Jul 12;20(31):4235-48. doi: 10.1038/sj.onc.1204585. Oncogene. 2001. PMID: 11464290

5

Mutational analysis of human thioredoxin reductase 1. Effects on p53-mediated gene expression and interferon and retinoic acid-induced cell death.

Ma X, Hu J, Lindner DJ, Kalvakolanu DV. Ma X, et al. J Biol Chem. 2002 Jun 21;277(25):22460-8. doi: 10.1074/jbc.M202286200. Epub 2002 Apr 12. J Biol Chem. 2002. PMID: 11953436 Free article.

6

Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.

Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, Gius D. Karimpour S, et al. Among authors: ma x. Oncogene. 2002 Sep 12;21(41):6317-27. doi: 10.1038/sj.onc.1205749. Oncogene. 2002. PMID: 12214272

7

Thioredoxin reductase plays a critical role in IFN retinoid-mediated tumor-growth control in vivo.

Lindner DJ, Ma X, Hu J, Karra S, Kalvakolanu DV. Lindner DJ, et al. Among authors: ma x. Clin Cancer Res. 2002 Oct;8(10):3210-8. Clin Cancer Res. 2002. PMID: 12374691

8

Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death.

Hu J, Angell JE, Zhang J, Ma X, Seo T, Raha A, Hayashi J, Choe J, Kalvakolanu DV. Hu J, et al. Among authors: ma x. J Interferon Cytokine Res. 2002 Oct;22(10):1017-26. doi: 10.1089/107999002760624242. J Interferon Cytokine Res. 2002. PMID: 12433281

9

Cyclooxygenase inhibitors modulate NK activities that control metastatic disease.

Kundu N, Walser TC, Ma X, Fulton AM. Kundu N, et al. Among authors: ma x. Cancer Immunol Immunother. 2005 Oct;54(10):981-7. doi: 10.1007/s00262-005-0669-2. Epub 2005 May 13. Cancer Immunol Immunother. 2005. PMID: 15891886 Free PMC article.

10

Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4.

Holt D, Ma X, Kundu N, Fulton A. Holt D, et al. Among authors: ma x. Cancer Immunol Immunother. 2011 Nov;60(11):1577-86. doi: 10.1007/s00262-011-1064-9. Epub 2011 Jun 17. Cancer Immunol Immunother. 2011. PMID: 21681369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,815 results

Search Page

Filters